KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for Fulgent Genetics (FLGT) over the last 8 years, with Q3 2025 value amounting to $2.3 million.

  • Fulgent Genetics' Current Deferred Revenue fell 2215.1% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 2215.1%. This contributed to the annual value of $2.2 million for FY2024, which is 2226.86% down from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Current Deferred Revenue is $2.3 million, which was down 2215.1% from $2.7 million recorded in Q2 2025.
  • Fulgent Genetics' Current Deferred Revenue's 5-year high stood at $14.6 million during Q4 2021, with a 5-year trough of $2.2 million in Q4 2024.
  • Moreover, its 5-year median value for Current Deferred Revenue was $2.8 million (2025), whereas its average is $5.4 million.
  • In the last 5 years, Fulgent Genetics' Current Deferred Revenue skyrocketed by 304414.41% in 2021 and then plummeted by 8061.98% in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Current Deferred Revenue stood at $14.6 million in 2021, then tumbled by 78.04% to $3.2 million in 2022, then dropped by 10.16% to $2.9 million in 2023, then decreased by 22.27% to $2.2 million in 2024, then increased by 3.36% to $2.3 million in 2025.
  • Its Current Deferred Revenue was $2.3 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.8 million in Q1 2025.